Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy
About this item
Full title
Author / Creator
De Biasi, Sara , Gibellini, Lara , Lo Tartaro, Domenico , Puccio, Simone , Rabacchi, Claudio , Mazza, Emilia M. C. , Brummelman, Jolanda , Williams, Brandon , Kaihara, Kelly , Forcato, Mattia , Bicciato, Silvio , Pinti, Marcello , Depenni, Roberta , Sabbatini, Roberto , Longo, Caterina , Dominici, Massimo , Pellacani, Giovanni , Lugli, Enrico and Cossarizza, Andrea
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Immune checkpoint inhibitors are used for treating patients with metastatic melanoma. Since the response to treatment is variable, biomarkers are urgently needed to identify patients who may benefit from such therapy. Here, we combine single-cell RNA-sequencing and multiparameter flow cytometry to assess changes in circulating CD8
+
T cells i...
Alternative Titles
Full title
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy
Authors, Artists and Contributors
Author / Creator
Gibellini, Lara
Lo Tartaro, Domenico
Puccio, Simone
Rabacchi, Claudio
Mazza, Emilia M. C.
Brummelman, Jolanda
Williams, Brandon
Kaihara, Kelly
Forcato, Mattia
Bicciato, Silvio
Pinti, Marcello
Depenni, Roberta
Sabbatini, Roberto
Longo, Caterina
Dominici, Massimo
Pellacani, Giovanni
Lugli, Enrico
Cossarizza, Andrea
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5dde8cd7955f4749b3113f29084ac913
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5dde8cd7955f4749b3113f29084ac913
Other Identifiers
ISSN
2041-1723
E-ISSN
2041-1723
DOI
10.1038/s41467-021-21928-4
